BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31597315)

  • 1. Quercetin, a Promising Clinical Candidate for The Prevention of Contrast-Induced Nephropathy.
    Vicente-Vicente L; González-Calle D; Casanova AG; Hernández-Sánchez MT; Prieto M; Rama-Merchán JC; Martín-Moreiras J; Martín-Herrero F; Sánchez PL; López-Hernández FJ; Cruz-González I; Morales AI
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
    Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
    Malhis M; Al-Bitar S; Al-Deen Zaiat K
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials.
    Xie J; Jiang M; Lin Y; Deng H; Li L
    Angiology; 2019 Aug; 70(7):594-612. PubMed ID: 30669852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
    Bilasy ME; Oraby MA; Ismail HM; Maklady FA
    J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
    Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
    Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
    Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
    Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
    J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
    Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
    Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
    Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
    Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Nyman U; Björk J; Aspelin P; Marenzi G
    Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
    Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
    Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
    Benko A; Fraser-Hill M; Magner P; Capusten B; Barrett B; Myers A; Owen RJ;
    Can Assoc Radiol J; 2007 Apr; 58(2):79-87. PubMed ID: 17521052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?
    Altunoren O; Balli M; Eren N; Tasolar H; Arpaci A; Caglayan CE; Yavuz YC; Gungor O
    Kidney Blood Press Res; 2015; 40(5):533-41. PubMed ID: 26496491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.